Heart Disease Trial, Recruiting NCT07167368 Sponsor: Haiyan Pan Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07167368
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a stable, long-term form of heart failure where the heart's pumping function is reduced, along with reduced kidney function (as measured by a specific kidney test result below a certain level)
  • People whose heart failure symptoms are moderate — meaning they have some limitations during physical activity but are comfortable at rest (this is referred to as NYHA class II or III, confirm with trial site)
  • People who are assessed as low risk when doing physical exercise (as determined by a medical assessment)
  • People aged between 18 and 75 years

Who may not be able to join:

  • People with high blood pressure that is not well controlled
  • People with serious heart rhythm problems, including certain types of irregular heartbeats, abnormally fast heart rhythms, or problems with the heart's electrical signalling system
  • People with a type of thickened heart muscle condition that blocks blood flow out of the heart
  • People with moderate to severe narrowing of one or more heart valves
  • People with a blood clot in a deep vein or in the lungs
  • People who have a history of fainting episodes
  • People with severely low red blood cell levels
  • People with thyroid function that is outside the normal range
  • People with serious lung conditions
  • People with mental illness
  • People with bone, joint, or muscle problems that would prevent them from taking part in physical rehabilitation exercises

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Haiyan Pan
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
31 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Difference in VO₂ peak (a marker of cardiopulmonary exercise tolerance) between the two groups before and after 6 months of treatment; Difference in 6-minute walk test (6MWT) distance (a marker of cardiopulmonary exercise tolerance) between the two groups before and after 6 months of treatment; Differences in estimated Glomerular Filtration Rate (eGFR) between the two groups before and after 6 months of treatment; Difference in Serum Creatinine (Scr) between the two groups before and after 6 months of treatment; Difference in Left Ventricular Ejection Fraction (LVEF) between the two groups bef...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov